Maurice Joseph Clancy

Title: Maurice Joseph Clancy: Innovator in Pharmaceutical Formulations

Introduction

Maurice Joseph Clancy is a notable inventor based in Athlone, Ireland. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of oral dosage forms.

Latest Patents

Clancy holds a patent for "Cisapride mini-tablet formulations." This innovative sustained-release oral dosage formulation is designed for once-daily administration. It comprises a plurality of mini-tablets containing cisapride or a salt thereof, combined with an organic acid. The formulation is capable of releasing cisapride at different sites along the gastrointestinal tract. The mini-tablets include both immediate-release and delayed-release components, which respond to the pH environment in the distal regions of the gastrointestinal tract. The formulation is characterized by a Cmax/Cmin ratio under steady-state conditions of 2:1 or less, as evidenced by a substantially flat plasma profile in vivo.

Career Highlights

Clancy is associated with Elan Corporation, Plc, where he has contributed to the advancement of pharmaceutical technologies. His work focuses on improving the efficacy and safety of drug delivery systems.

Collaborations

One of Clancy's notable collaborators is Kenneth Iain Cumming. Together, they have worked on various projects aimed at enhancing pharmaceutical formulations.

Conclusion

Maurice Joseph Clancy's innovative work in the field of pharmaceutical formulations has made a significant impact on drug delivery systems. His contributions continue to influence the development of effective oral dosage forms.